Professor Camm graduated from Guy's Hospital, London and pursued a career in Cardiology at St. Bartholomew's Hospital. In 1986 he moved to the Chair of Clinical Cardiology at St. George's Hospital. Professor Camm is Chairman of the Department of Cardiovascular Sciences and the Division of Cardiological Sciences and is past Chairman of the Department of Medicine at St. George's. Professor Camm is particularly interested in clinical cardiac electrophysiology, cardiac arrhythmias and implantable devices for rhythm control. He is past Chairman of the European Society of Cardiology Working Group on Cardiac Arrhythmias, past President of the British Pacing & Electrophysiology Group and a past council member of the Royal College of Physicians. He is a former Trustee of the North American Society of Pacing and Electrophysiology and he is the past President of the British Cardiac Society. He is currently Convenor of Medicine, University of London and Chairman of the Joint Cardiology Committee (Royal College of Physicians). Professor Camm has travelled extensively and is recognised internationally for his research and teaching. Professor Camm is a worldwide renowned trialist and holds memberships in 18 multicentre study committees, including DIAMOND (Danish Investigation of Arrhythmias and Mortality on Dofetilide), ATRAMI (Autonomic Tone and Reflexes after Myocardial Infarction), ELITE II (Effects of Losartan in the Elderly), ALIVE (Azimilide Post-Infarct Survival Evaluation), and DAPHNE (Dronedarone Atrial Fibrillation Post Conversion Evaluation).
Some of Professor Camm's most important peer-reviewed publications include:
- The successful cryosurgical treatment of paroxysmal ventricular tachycardia. Chest 1979;75:621–624
- Cryothermal mapping and cryoablation in the treatment of refractory cardiac arrhythmias. Circulation 1980;62:67–74
- Surgery for ventricular tachycardia. Lancet 1980;i:579
- The rhythm of the heart in active elderly subjects. Am Heart J 1980;99:598–603
- The acute cardiac electrophysiological effects of intravenous metoprolol. Clin Cardiol 1982;5:327–331
- Clinical investigation of implantable antitachycardia devices: Report of the policy conference of the North American Society of Pacing and Electrophysiology. J Am Coll Cardiol 1987;10:225–229
- Mechanism of Wenckebach periods—a hypothesis based on computer modelling experiments. Am J Physiol 1989;257:H1263–H1274
- Heart rate variability. Clin Cardiol 1990;13:570–576
- Drug therapy: Adenosine and supraventricular tachycardia. N Engl J Med 1991;325:1621–1629
- Implantable defibrillators for prevention of sudden death. Technology at a medical and economic crossroad. Circulation 1992;85(6):2316–2321
- An implantable atrial defibrillator. An impossible dream? Circulation 1993;87:1769–1772
- Atrial arrhythmias. Lancet 1993;341:1317–1322
- Drug therapy: Quinidine N Engl J Med 1998;338:35–45
- Atrioverter: An implantable device for the treatment of atrial fibrillation Circulation 1998;98:1651–1656
- Congenital and acquired long QT syndrome. Eur Heart J 2000;21:1232–1237
- Depressed heart rate variability identifies postinfarction patients who might benefit from prophylactic treatment with amiodarone: A substudy of EMIAT (The European Myocardial Infarct Amiodarone Trial) J Am Coll Cardiol 2000;35:1263–1275
- New approaches to antiarrhythmic therapy, Part I. Circulation 2001;104:2865–2873
- New approaches to antiarrhythmic therapy, Part II. Circulation 2001;104:2990–2994
- Quality of life in patients with silent atrial fibrillation. Heart 2001;356:2052–2058
